Clinical Trials · NCT02349802
Autoinjector Device Assessment Study
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 3,052
- Start date
- Feb 2013
- Locations
- 2 sites, United States
- Primary endpoint
- Number of device-related failure injections